Pharma-Bio Serv Income Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 31, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Revenue	8.82	9	9.51	16.98	19.4	20.12
Revenue Growth (YoY)	-8.08%	-5.34%	-43.99%	-12.48%	-3.56%	-6.72%
Cost of Revenue	5.96	6.09	6.99	11.91	14.52	14.76
Gross Profit	2.86	2.91	2.52	5.07	4.88	5.36
Selling, General & Admin	3.5	3.55	3.8	3.95	3.71	4.01
Operating Expenses	3.5	3.55	3.8	3.95	3.71	9.21
Operating Income	-0.64	-0.64	-1.29	1.12	1.17	-3.85
Interest & Investment Income	0.64	0.64	0.53	-	-	-
Currency Exchange Gain (Loss)	-0.1	-0.1	-	-	-	-
Other Non Operating Income (Expenses)	0.03	-	-	0.57	0.01	0.02
EBT Excluding Unusual Items	-0.07	-0.09	-0.76	1.69	1.19	-3.83
Other Unusual Items	-	-	-	-	-	1.96
Pretax Income	-0.07	-0.09	-0.76	1.69	1.19	-1.88
Income Tax Expense	0.01	0.01	0.02	0.38	0.18	0.21
Earnings From Continuing Operations	-0.08	-0.1	-0.78	1.31	1.01	-2.09
Net Income	-0.08	-0.1	-0.78	1.31	1.01	-2.09
Net Income to Common	-0.08	-0.1	-0.78	1.31	1.01	-2.09
Net Income Growth	-	-	-	30.15%	-	-
Shares Outstanding (Basic)	23	23	23	23	23	23
Shares Outstanding (Diluted)	23	23	23	23	23	23
Shares Change (YoY)	-0.13%	-0.07%	-0.10%	-0.15%	-0.56%	0.53%
EPS (Basic)	-0.00	-0.00	-0.03	0.06	0.04	-0.09
EPS (Diluted)	-0.00	-0.00	-0.03	0.06	0.04	-0.09
EPS Growth	-	-	-	30.25%	-	-
Free Cash Flow	-0.18	-0.22	-0.73	1.88	0.57	0.79
Free Cash Flow Per Share	-0.01	-0.01	-0.03	0.08	0.03	0.03
Gross Margin	32.46%	32.33%	26.46%	29.84%	25.16%	26.65%
Operating Margin	-7.25%	-7.08%	-13.54%	6.58%	6.06%	-19.16%
Profit Margin	-0.86%	-1.12%	-8.18%	7.72%	5.19%	-10.39%
Free Cash Flow Margin	-2.09%	-2.46%	-7.64%	11.10%	2.96%	3.95%
EBITDA	-0.57	-0.58	-1.26	1.17	1.23	-3.78
EBITDA Margin	-6.51%	-6.42%	-13.30%	6.87%	6.32%	-18.80%
D&A For EBITDA	0.07	0.06	0.02	0.05	0.05	0.07
EBIT	-0.64	-0.64	-1.29	1.12	1.17	-3.85
EBIT Margin	-7.25%	-7.08%	-13.54%	6.58%	6.06%	-19.16%
Effective Tax Rate	-	-	-	22.36%	15.29%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.